ESC Premium Access

Impact of plaque vulnerability on vascular response after implantation of two types of biodegradable-polymer drug-eluting stent: coronary angioscopic study.

Congress Presentation

About the speaker

Doctor Minoru Ichikawa

Higashi-Osaka City Medical Center, Higashiosaka (Japan)
0 follower

26 more presentations in this session

Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free biolimus A9-coated stent: insights from the all-comers FREEDOM registry

Speaker: Doctor G. Gallone (Turin, IT)


Long term clinical outcome of a novel sirolimus-eluting coronary stent in patients with acute myocardial infarction

Speaker: Doctor S. Dani (Ahmedabad, IN)


Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study

Speaker: Doctor H. Matsuda (Nagoya, JP)


Clinical outcomes of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention

Speaker: Doctor I. Menown (Craigavon, GB)


Final 5-year outcomes of the TRIAS High Risk of Restenosis; a multi-centre, randomized trial comparing endothelial progenitor cell capturing stent with drug-eluting stents

Speaker: Miss L. Kerkmeijer (Zwolle, NL)


Access the full session

Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

Speakers: Doctor M. Ichikawa, Doctor G. Gallone, Doctor S. Dani, Doctor H. Matsuda, Doctor I. Menown...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb